VHIO leads research proposing cerebrospinal fluid as liquid biopsy for the early diagnosis, prognosis, therapeutic management and tracking of brain cancer Reported in the journal Nature Communications, the Vall d’Hebron Institute of Oncology´s (VHIO) Gene Expression and Cancer Group, led ...
Read More »